231 related articles for article (PubMed ID: 30422139)
21. Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles.
Hu Z; Yang B; Li T; Li J
Contrast Media Mol Imaging; 2018; 2018():8710862. PubMed ID: 29706844
[TBL] [Abstract][Full Text] [Related]
22. A nanosystem loaded with perfluorohexane and rose bengal coupled upconversion nanoparticles for multimodal imaging and synergetic chemo-photodynamic therapy of cancer.
Wang HY; Hou L; Li HL; Wang X; Cao Y; Zhang BY; Wang JT; Wei SJ; Dang HW; Ran HT
Biomater Sci; 2020 May; 8(9):2488-2506. PubMed ID: 32211626
[TBL] [Abstract][Full Text] [Related]
23. Camptothecin-loaded fusogenic nanodroplets as ultrasound theranostic agent in stem cell-mediated drug-delivery system.
Ho YJ; Chiang YJ; Kang ST; Fan CH; Yeh CK
J Control Release; 2018 May; 278():100-109. PubMed ID: 29630986
[TBL] [Abstract][Full Text] [Related]
24. EGFR-targeted liposomal nanohybrid cerasomes: theranostic function and immune checkpoint inhibition in a mouse model of colorectal cancer.
Li Y; Du Y; Liang X; Sun T; Xue H; Tian J; Jin Z
Nanoscale; 2018 Sep; 10(35):16738-16749. PubMed ID: 30156250
[TBL] [Abstract][Full Text] [Related]
25. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.
Liu Y; Gunda V; Zhu X; Xu X; Wu J; Askhatova D; Farokhzad OC; Parangi S; Shi J
Proc Natl Acad Sci U S A; 2016 Jul; 113(28):7750-5. PubMed ID: 27342857
[TBL] [Abstract][Full Text] [Related]
26. Cetuximab-oxaliplatin-liposomes for epidermal growth factor receptor targeted chemotherapy of colorectal cancer.
Zalba S; Contreras AM; Haeri A; Ten Hagen TL; Navarro I; Koning G; Garrido MJ
J Control Release; 2015 Jul; 210():26-38. PubMed ID: 25998052
[TBL] [Abstract][Full Text] [Related]
27. GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer.
Huang H; Dong Y; Zhang Y; Ru D; Wu Z; Zhang J; Shen M; Duan Y; Sun Y
Theranostics; 2019; 9(4):1047-1065. PubMed ID: 30867815
[No Abstract] [Full Text] [Related]
28. Multifunctional Drug-Loaded Phase-Change Nanoparticles Inhibit the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Affecting the Activity of Activated Hepatic Stellate Cells.
Zou X; Li T; Mao Y; Zhu M; Chen X; Niu J; Dong T; Jiang J; Yang X
Biomed Res Int; 2022; 2022():6441179. PubMed ID: 36411770
[No Abstract] [Full Text] [Related]
29. Fe
Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
[TBL] [Abstract][Full Text] [Related]
30. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell.
Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y
Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098
[TBL] [Abstract][Full Text] [Related]
31. Drug Release from Gelsolin-Targeted Phase-Transition Nanoparticles Triggered by Low-Intensity Focused Ultrasound.
Qin H; Teng R; Liu Y; Li J; Yu M
Int J Nanomedicine; 2022; 17():61-71. PubMed ID: 35023919
[TBL] [Abstract][Full Text] [Related]
32. Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release.
Qiao H; Cui Z; Yang S; Ji D; Wang Y; Yang Y; Han X; Fan Q; Qin A; Wang T; He XP; Bu W; Tang T
ACS Nano; 2017 Jul; 11(7):7259-7273. PubMed ID: 28692257
[TBL] [Abstract][Full Text] [Related]
33. Targeted delivery of monoclonal antibody conjugated docetaxel loaded PLGA nanoparticles into EGFR overexpressed lung tumour cells.
Patel J; Amrutiya J; Bhatt P; Javia A; Jain M; Misra A
J Microencapsul; 2018 Mar; 35(2):204-217. PubMed ID: 29542378
[TBL] [Abstract][Full Text] [Related]
34. A Multifunctional Theranostic Nanoagent for Dual-Mode Image-Guided HIFU/Chemo- Synergistic Cancer Therapy.
Zhang N; Cai X; Gao W; Wang R; Xu C; Yao Y; Hao L; Sheng D; Chen H; Wang Z; Zheng Y
Theranostics; 2016; 6(3):404-17. PubMed ID: 26909114
[TBL] [Abstract][Full Text] [Related]
35. Echogenic Glycol Chitosan Nanoparticles for Ultrasound-Triggered Cancer Theranostics.
Min HS; You DG; Son S; Jeon S; Park JH; Lee S; Kwon IC; Kim K
Theranostics; 2015; 5(12):1402-18. PubMed ID: 26681985
[TBL] [Abstract][Full Text] [Related]
36. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
Tseng SH; Chou MY; Chu IM
Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
[TBL] [Abstract][Full Text] [Related]
37. Chemical gas-generating nanoparticles for tumor-targeted ultrasound imaging and ultrasound-triggered drug delivery.
Min HS; Son S; You DG; Lee TW; Lee J; Lee S; Yhee JY; Lee J; Han MH; Park JH; Kim SH; Choi K; Park K; Kim K; Kwon IC
Biomaterials; 2016 Nov; 108():57-70. PubMed ID: 27619240
[TBL] [Abstract][Full Text] [Related]
38. Microwave-activated nanodroplet vaporization for highly efficient tumor ablation with real-time monitoring performance.
Xu J; Chen Y; Deng L; Liu J; Cao Y; Li P; Ran H; Zheng Y; Wang Z
Biomaterials; 2016 Nov; 106():264-75. PubMed ID: 27573134
[TBL] [Abstract][Full Text] [Related]
39. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
40. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
